324 related articles for article (PubMed ID: 17724140)
1. BMP7, a putative regulator of epithelial homeostasis in the human prostate, is a potent inhibitor of prostate cancer bone metastasis in vivo.
Buijs JT; Rentsch CA; van der Horst G; van Overveld PG; Wetterwald A; Schwaninger R; Henriquez NV; Ten Dijke P; Borovecki F; Markwalder R; Thalmann GN; Papapoulos SE; Pelger RC; Vukicevic S; Cecchini MG; Löwik CW; van der Pluijm G
Am J Pathol; 2007 Sep; 171(3):1047-57. PubMed ID: 17724140
[TBL] [Abstract][Full Text] [Related]
2. Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer.
Buijs JT; Henriquez NV; van Overveld PG; van der Horst G; Que I; Schwaninger R; Rentsch C; Ten Dijke P; Cleton-Jansen AM; Driouch K; Lidereau R; Bachelier R; Vukicevic S; Clézardin P; Papapoulos SE; Cecchini MG; Löwik CW; van der Pluijm G
Cancer Res; 2007 Sep; 67(18):8742-51. PubMed ID: 17875715
[TBL] [Abstract][Full Text] [Related]
3. Diverse biological effect and Smad signaling of bone morphogenetic protein 7 in prostate tumor cells.
Yang S; Zhong C; Frenkel B; Reddi AH; Roy-Burman P
Cancer Res; 2005 Jul; 65(13):5769-77. PubMed ID: 15994952
[TBL] [Abstract][Full Text] [Related]
4. BMP7: a new bone metastases prevention?
Fournier PG; Guise TA
Am J Pathol; 2007 Sep; 171(3):739-43. PubMed ID: 17690188
[No Abstract] [Full Text] [Related]
5. Bone morphogenetic protein 7 in dormancy and metastasis of prostate cancer stem-like cells in bone.
Kobayashi A; Okuda H; Xing F; Pandey PR; Watabe M; Hirota S; Pai SK; Liu W; Fukuda K; Chambers C; Wilber A; Watabe K
J Exp Med; 2011 Dec; 208(13):2641-55. PubMed ID: 22124112
[TBL] [Abstract][Full Text] [Related]
6. Bone morphogenetic protein 7 induces mesenchymal-to-epithelial transition in melanoma cells, leading to inhibition of metastasis.
Na YR; Seok SH; Kim DJ; Han JH; Kim TH; Jung H; Lee BH; Park JH
Cancer Sci; 2009 Nov; 100(11):2218-25. PubMed ID: 19735263
[TBL] [Abstract][Full Text] [Related]
7. Secreted Protein Acidic and Rich in Cysteine (SPARC) Mediates Metastatic Dormancy of Prostate Cancer in Bone.
Sharma S; Xing F; Liu Y; Wu K; Said N; Pochampally R; Shiozawa Y; Lin HK; Balaji KC; Watabe K
J Biol Chem; 2016 Sep; 291(37):19351-63. PubMed ID: 27422817
[TBL] [Abstract][Full Text] [Related]
8. Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer.
Feeley BT; Gamradt SC; Hsu WK; Liu N; Krenek L; Robbins P; Huard J; Lieberman JR
J Bone Miner Res; 2005 Dec; 20(12):2189-99. PubMed ID: 16294272
[TBL] [Abstract][Full Text] [Related]
9. Bone morphogenetic protein 7 protects prostate cancer cells from stress-induced apoptosis via both Smad and c-Jun NH2-terminal kinase pathways.
Yang S; Lim M; Pham LK; Kendall SE; Reddi AH; Altieri DC; Roy-Burman P
Cancer Res; 2006 Apr; 66(8):4285-90. PubMed ID: 16618753
[TBL] [Abstract][Full Text] [Related]
10. p38MAPK acts in the BMP7-dependent stimulatory pathway during epithelial cell morphogenesis and is regulated by Smad1.
Hu MC; Wasserman D; Hartwig S; Rosenblum ND
J Biol Chem; 2004 Mar; 279(13):12051-9. PubMed ID: 14718543
[TBL] [Abstract][Full Text] [Related]
11. Targeting of α(v)-integrins in stem/progenitor cells and supportive microenvironment impairs bone metastasis in human prostate cancer.
van der Horst G; van den Hoogen C; Buijs JT; Cheung H; Bloys H; Pelger RC; Lorenzon G; Heckmann B; Feyen J; Pujuguet P; Blanque R; Clément-Lacroix P; van der Pluijm G
Neoplasia; 2011 Jun; 13(6):516-25. PubMed ID: 21677875
[TBL] [Abstract][Full Text] [Related]
12. Targeting the BMP Pathway in Prostate Cancer Induced Bone Disease.
Straign DM; Ihle CL; Provera MD; Owens P
Front Endocrinol (Lausanne); 2021; 12():769316. PubMed ID: 34956082
[TBL] [Abstract][Full Text] [Related]
13. Bone morphogenetic protein 7 inhibits tumor growth of human uveal melanoma in vivo.
Notting I; Buijs J; Mintardjo R; van der Horst G; Vukicevic S; Lowik C; Schalij-Delfos N; Keunen J; van der Pluijm G
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):4882-9. PubMed ID: 17962434
[TBL] [Abstract][Full Text] [Related]
14. The BMP2/7 heterodimer inhibits the human breast cancer stem cell subpopulation and bone metastases formation.
Buijs JT; van der Horst G; van den Hoogen C; Cheung H; de Rooij B; Kroon J; Petersen M; van Overveld PG; Pelger RC; van der Pluijm G
Oncogene; 2012 Apr; 31(17):2164-74. PubMed ID: 21996751
[TBL] [Abstract][Full Text] [Related]
15. Role of Bone Morphogenetic Protein 7 (BMP7) in the Modulation of Corneal Stromal and Epithelial Cell Functions.
Kowtharapu BS; Prakasam RK; Murín R; Koczan D; Stahnke T; Wree A; Jünemann AGM; Stachs O
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29747422
[TBL] [Abstract][Full Text] [Related]
16. Bone morphogenetic proteins enhance an epithelial-mesenchymal transition in normal airway epithelial cells during restitution of a disrupted epithelium.
McCormack N; Molloy EL; O'Dea S
Respir Res; 2013 Mar; 14(1):36. PubMed ID: 23509993
[TBL] [Abstract][Full Text] [Related]
17. The aldehyde dehydrogenase enzyme 7A1 is functionally involved in prostate cancer bone metastasis.
van den Hoogen C; van der Horst G; Cheung H; Buijs JT; Pelger RC; van der Pluijm G
Clin Exp Metastasis; 2011 Oct; 28(7):615-25. PubMed ID: 21647815
[TBL] [Abstract][Full Text] [Related]
18. BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury.
Zeisberg M; Hanai J; Sugimoto H; Mammoto T; Charytan D; Strutz F; Kalluri R
Nat Med; 2003 Jul; 9(7):964-8. PubMed ID: 12808448
[TBL] [Abstract][Full Text] [Related]
19. BMP7 inhibits branching morphogenesis in the prostate gland and interferes with Notch signaling.
Grishina IB; Kim SY; Ferrara C; Makarenkova HP; Walden PD
Dev Biol; 2005 Dec; 288(2):334-47. PubMed ID: 16324690
[TBL] [Abstract][Full Text] [Related]
20. PI3K, Erk signaling in BMP7-induced epithelial-mesenchymal transition (EMT) of PC-3 prostate cancer cells in 2- and 3-dimensional cultures.
Lim M; Chuong CM; Roy-Burman P
Horm Cancer; 2011 Oct; 2(5):298-309. PubMed ID: 21948155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
